Skip to Main Content
Upsher-Smith in 2024: Statement on What We’re Committed to, and Capable of, Doing in the New Year

News

Sawai Receives Approvals for Two Generic Drugs with Five Strengths

Osaka, Japan – August 15, 2019 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) received approvals by the Ministry of Health, Labour and Welfare for two generic drugs with five strengths. The two compounds, Aprepitant and Micafungin Sodium are approved for the first time ...
Read More
Careers

Join Our Team!

We’re hiring

Search Our Jobs

Close